Financials

News Ideas Minds

IP4 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of INNOCAN PHARMA CORP.

Total assets of IP4 for Q1 24 is 8.37 M EUR, 33.79% more than the previous Q4 23. And total liabilities increased by 74.26% in Q1 24 to 4.01 M EUR.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—